CIK: 0001846444 · Show all filings
Period: Q3 2021 (Next →)
Filing Date: Nov 12, 2021
Total Value ($000): $663,202 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PATH | UIPATH INC | 3,811,779 | $200,538 | 30.2% | $60.53 | 0.0% | COM CL A | 90364P105 |
| DASH | DOORDASH INC | 630,217 | $129,812 | 19.6% | $191.28 | 0.0% | COM CL A | 25809K105 |
| — | DICE THERAPEUTICS, INC. | 3,148,970 | $103,129 | 15.6% | $32.75 | — | COM | 23345J104 |
| SNOW | SNOWFLAKE INC | 316,576 | $95,742 | 14.4% | $284.41 | 0.0% | COM CL A | 833445109 |
| ABOS | ACUMEN PHARMACEUTICALS, INC | 3,417,075 | $50,778 | 7.7% | $16.64 | 0.0% | COM | 00509G209 |
| — | KARUNA THERAPEUTICS, INC. | 267,895 | $32,772 | 4.9% | $122.33 | — | COM | 48576A100 |
| TSHA | TAYSHA GENE THERAPIES INC | 724,873 | $13,497 | 2.0% | $19.01 | 0.0% | COM | 877619106 |
| MASS | 908 DEVICES INC | 326,427 | $10,615 | 1.6% | $33.97 | 0.0% | COM | 65443P102 |
| CADL | CANDEL THERAPEUTICS, INC | 811,737 | $8,799 | 1.3% | $8.29 | 0.0% | COM | 137404109 |
| RGEN | REPLIGEN CORP. | 22,544 | $6,515 | 1.0% | $256.54 | 0.0% | COM | 759916109 |
| TARS | TARSUS PHARMACEUTICALS INC | 260,000 | $5,603 | 0.8% | $24.75 | 0.0% | COM | 87650L103 |
| — | SPRUCE BIOSCIENCES INC | 787,007 | $4,730 | 0.7% | $6.01 | — | COM | 85209E109 |
| ABSI | ABSCI CORP. | 57,804 | $672 | 0.1% | $19.41 | 0.0% | COM | 00091E109 |